OSSIX Bone
Commercial- Indications
- Dental bone regeneration
Company intelligence / Profile preview
Datum Dental developed the OSSIX® portfolio of dental regenerative solutions powered by its patented GLYMATRIX® technology. These products are clinically proven for predictable long-term results in guided bone/tissue regeneration. The company was acquired by Dentsply Sirona in January 2021 to complement their implant dentistry strategy. Products have been used worldwide across hundreds of thousands of procedures with strong clinical validation.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Datum Dental.